Tower Research Capital LLC (TRC) - FIBROGEN INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of FIBROGEN INC
ValueSharesWeighting
Q3 2023$10,402
-79.8%
12,053
-36.8%
0.00%
-100.0%
Q2 2023$51,494
+81636.5%
19,072
+463.4%
0.00%0.0%
Q1 2023$63
+293.8%
3,385
+231.2%
0.00%
+100.0%
Q4 2022$16
-100.0%
1,022
-92.7%
0.00%
-66.7%
Q3 2022$182,000
+17.4%
14,002
-4.5%
0.00%0.0%
Q2 2022$155,000
+10.7%
14,665
+25.2%
0.00%
+200.0%
Q1 2022$140,000
-7.3%
11,712
+9.9%
0.00%
-66.7%
Q4 2021$151,000
+12.7%
10,655
-18.4%
0.00%0.0%
Q3 2021$134,000
-15.7%
13,064
+119.6%
0.00%
-25.0%
Q2 2021$159,000
-55.5%
5,949
-42.2%
0.00%
-33.3%
Q1 2021$357,000
+86.9%
10,292
+100.2%
0.01%0.0%
Q4 2020$191,000
-35.0%
5,141
-28.1%
0.01%
+100.0%
Q3 2020$294,000
-32.9%
7,151
-33.9%
0.00%
-83.3%
Q2 2020$438,000
+73.1%
10,812
+83.3%
0.02%
-14.3%
Q4 2019$253,000
+12550.0%
5,899
+13306.8%
0.02%
Q2 2019$2,000
-94.4%
44
-93.4%
0.00%
-100.0%
Q1 2019$36,000
+800.0%
668
+650.6%
0.00%
Q4 2018$4,000
-90.7%
89
-87.5%
0.00%
-100.0%
Q3 2018$43,000
+377.8%
714
+290.2%
0.00%
+200.0%
Q4 2017$9,000
-96.3%
183
-96.0%
0.00%
-95.0%
Q3 2017$245,000
+2127.3%
4,560
+1188.1%
0.02%
+1900.0%
Q2 2017$11,000
-80.4%
354
-86.5%
0.00%
-83.3%
Q4 2016$56,000
+2700.0%
2,616
+2516.0%
0.01%
Q3 2016$2,000
-66.7%
100
-50.0%
0.00%
-100.0%
Q4 2015$6,000
-50.0%
200
-62.8%
0.00%0.0%
Q3 2015$12,000
+140.0%
537
+165.8%
0.00%
Q2 2015$5,000
-78.3%
202
-73.2%
0.00%
-100.0%
Q1 2015$23,0007540.00%
Other shareholders
FIBROGEN INC shareholders Q4 2023
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,017,250$126,280,00012.02%
Omega Fund Management, LLC 130,646$8,178,0006.03%
Opaleye Management Inc. 360,000$22,536,0005.83%
Hillhouse Capital Management 2,686,196$168,156,0002.87%
Opus Point Partners Management, LLC 18,423$1,153,0002.50%
DOHENY ASSET MANAGEMENT /CA 50,880$3,185,0001.73%
Rhenman & Partners Asset Management AB 239,547$14,996,0001.54%
NEXTHERA CAPITAL LP 135,583$8,487,0001.31%
FORTALEZA ASSET MANAGEMENT INC/ 2,405$151,0001.22%
Handelsinvest Investeringsforvaltning 71,400$4,470,0000.98%
View complete list of FIBROGEN INC shareholders